A cutting edge overview: Psoriatic disease

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Psoriasis is a lifelong skin disease, affecting about 2% of the global population. Generalized involvement of the body (erythroderma), extensive pustular lesions, and an associated arthritis known as psoriatic arthritis (PsA) are severe complications of psoriasis. Genetic, immunologic, and environmental factors contribute to its pathogenesis. A complete understanding of the pathogenesis of psoriasis and psoriatic arthritis is lacking. Cytokines, chemokines, adhesion molecules, growth factors like NGF, neuropeptides, and T cell receptors all act in an integrated way to evolve into unique inflammatory and proliferative processes typical of psoriasis and PsA. Management of psoriasis requires exemplary skin care along with careful monitoring of arrays of comorbidities which includes arthritis and coronary artery disease. In many ways, psoriasis can be considered a model autoimmune disease. This statement itself is ironic considering that it was not recognized as immune mediated until relatively recently. Fortunately, the immunobiology has made enormous strides and there are now excellent therapeutic options for patients. In this thematic review, we have attempted to provide summaries of not only basic science and clinical research, but also an overview of future research directions.

Original languageEnglish (US)
Pages (from-to)109-113
Number of pages5
JournalClinical Reviews in Allergy and Immunology
Volume44
Issue number2
DOIs
StatePublished - 2013

Fingerprint

Psoriasis
Psoriatic Arthritis
Arthritis
Exfoliative Dermatitis
Skin Care
Immunologic Factors
Nerve Growth Factor
T-Cell Antigen Receptor
Neuropeptides
Chemokines
Skin Diseases
Autoimmune Diseases
Comorbidity
Coronary Artery Disease
Intercellular Signaling Peptides and Proteins
Cytokines
Research
Population

Keywords

  • Biologics
  • Epidemiology
  • Imaging
  • Inflammation
  • Psoriasis
  • Psoriatic arthritis

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

A cutting edge overview : Psoriatic disease. / Raychaudhuri, Siba P.

In: Clinical Reviews in Allergy and Immunology, Vol. 44, No. 2, 2013, p. 109-113.

Research output: Contribution to journalArticle

@article{75e3f3a4977847818714ec349f0ab78b,
title = "A cutting edge overview: Psoriatic disease",
abstract = "Psoriasis is a lifelong skin disease, affecting about 2{\%} of the global population. Generalized involvement of the body (erythroderma), extensive pustular lesions, and an associated arthritis known as psoriatic arthritis (PsA) are severe complications of psoriasis. Genetic, immunologic, and environmental factors contribute to its pathogenesis. A complete understanding of the pathogenesis of psoriasis and psoriatic arthritis is lacking. Cytokines, chemokines, adhesion molecules, growth factors like NGF, neuropeptides, and T cell receptors all act in an integrated way to evolve into unique inflammatory and proliferative processes typical of psoriasis and PsA. Management of psoriasis requires exemplary skin care along with careful monitoring of arrays of comorbidities which includes arthritis and coronary artery disease. In many ways, psoriasis can be considered a model autoimmune disease. This statement itself is ironic considering that it was not recognized as immune mediated until relatively recently. Fortunately, the immunobiology has made enormous strides and there are now excellent therapeutic options for patients. In this thematic review, we have attempted to provide summaries of not only basic science and clinical research, but also an overview of future research directions.",
keywords = "Biologics, Epidemiology, Imaging, Inflammation, Psoriasis, Psoriatic arthritis",
author = "Raychaudhuri, {Siba P}",
year = "2013",
doi = "10.1007/s12016-012-8309-z",
language = "English (US)",
volume = "44",
pages = "109--113",
journal = "Clinical Reviews in Allergy and Immunology",
issn = "1080-0549",
publisher = "Humana Press",
number = "2",

}

TY - JOUR

T1 - A cutting edge overview

T2 - Psoriatic disease

AU - Raychaudhuri, Siba P

PY - 2013

Y1 - 2013

N2 - Psoriasis is a lifelong skin disease, affecting about 2% of the global population. Generalized involvement of the body (erythroderma), extensive pustular lesions, and an associated arthritis known as psoriatic arthritis (PsA) are severe complications of psoriasis. Genetic, immunologic, and environmental factors contribute to its pathogenesis. A complete understanding of the pathogenesis of psoriasis and psoriatic arthritis is lacking. Cytokines, chemokines, adhesion molecules, growth factors like NGF, neuropeptides, and T cell receptors all act in an integrated way to evolve into unique inflammatory and proliferative processes typical of psoriasis and PsA. Management of psoriasis requires exemplary skin care along with careful monitoring of arrays of comorbidities which includes arthritis and coronary artery disease. In many ways, psoriasis can be considered a model autoimmune disease. This statement itself is ironic considering that it was not recognized as immune mediated until relatively recently. Fortunately, the immunobiology has made enormous strides and there are now excellent therapeutic options for patients. In this thematic review, we have attempted to provide summaries of not only basic science and clinical research, but also an overview of future research directions.

AB - Psoriasis is a lifelong skin disease, affecting about 2% of the global population. Generalized involvement of the body (erythroderma), extensive pustular lesions, and an associated arthritis known as psoriatic arthritis (PsA) are severe complications of psoriasis. Genetic, immunologic, and environmental factors contribute to its pathogenesis. A complete understanding of the pathogenesis of psoriasis and psoriatic arthritis is lacking. Cytokines, chemokines, adhesion molecules, growth factors like NGF, neuropeptides, and T cell receptors all act in an integrated way to evolve into unique inflammatory and proliferative processes typical of psoriasis and PsA. Management of psoriasis requires exemplary skin care along with careful monitoring of arrays of comorbidities which includes arthritis and coronary artery disease. In many ways, psoriasis can be considered a model autoimmune disease. This statement itself is ironic considering that it was not recognized as immune mediated until relatively recently. Fortunately, the immunobiology has made enormous strides and there are now excellent therapeutic options for patients. In this thematic review, we have attempted to provide summaries of not only basic science and clinical research, but also an overview of future research directions.

KW - Biologics

KW - Epidemiology

KW - Imaging

KW - Inflammation

KW - Psoriasis

KW - Psoriatic arthritis

UR - http://www.scopus.com/inward/record.url?scp=84879374570&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879374570&partnerID=8YFLogxK

U2 - 10.1007/s12016-012-8309-z

DO - 10.1007/s12016-012-8309-z

M3 - Article

C2 - 22359072

AN - SCOPUS:84879374570

VL - 44

SP - 109

EP - 113

JO - Clinical Reviews in Allergy and Immunology

JF - Clinical Reviews in Allergy and Immunology

SN - 1080-0549

IS - 2

ER -